Exelixis, Inc. (EXEL) financial statements (2022 and earlier)

Company profile

Business Address 1851 HARBOR BAY PARKWAY
ALAMEDA, CA 94502
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,4671,207852693388420169
Cash and cash equivalents647319267315183152142
Short-term investments82088758637920526825
Other undisclosed cash, cash equivalents, and short-term investments      2
Restricted cash and investments15   1  
Receivables28316111916381425
Inventory, net of allowances, customer advances and progress billings27211310733
Inventory27211310733
Contract with customer, asset  1 
Other undisclosed current assets42572631952
Total current assets:1,8351,4451,011897485471179
Noncurrent Assets
Property, plant and equipment1046749512621
Long-term investments and receivables371332536157645684
Long-term investments371332536157645684
Intangible assets, net (including goodwill)64646464646464
Goodwill64646464646464
Restricted cash and investments   1543
Deferred income tax assets112157172
Other noncurrent assets131725321212
Other undisclosed noncurrent assets   250   
Total noncurrent assets:781692874525170127154
TOTAL ASSETS:2,6162,1371,8861,422655598332
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities861197365474828
Accounts payable242412111076
Accrued liabilities 442422162118
Employee-related liabilities6251373221204
Deferred revenue82 
Debt  3  189 
Restructuring reserve      3
Customer refund liability342119158  
Deferred revenue and credits3220 
Other liabilities53      
Other undisclosed current liabilities156634826291421
Total current liabilities:33820514310511527152
Noncurrent Liabilities
Long-term debt and lease obligation514948   381
Long-term debt, excluding current maturities      381
Operating lease, liability514948
Liabilities, other than long-term debt1749172552383
Deferred revenue and credits239237 
Deferred revenue947
Contract with customer, liability16
Restructuring reserve      1
Other liabilities81211712
Other undisclosed noncurrent liabilities   12   
Total noncurrent liabilities:68545729255238384
Total liabilities:406258200135370508437
Stockholders' equity
Stockholders' equity attributable to parent2,2111,8791,6861,28728589(104)
Common stock0000000
Additional paid in capital2,4282,3222,2422,1682,1142,0731,833
Accumulated other comprehensive income (loss)(1)43(1)(0)(0)(0)
Accumulated deficit(217)(448)(559)(880)(1,829)(1,983)(1,937)
Total stockholders' equity:2,2111,8791,6861,28728589(104)
TOTAL LIABILITIES AND EQUITY:2,6162,1371,8861,422655598332

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,43598896885445219137
Revenue, net45219137
Cost of revenue
(Cost of Goods and Services Sold)
(53)(36)(33)(26)(1)(1)(1)
Gross profit:1,38295193582745119136
Operating expenses(1,095)(841)(598)(415)(287)(220)(159)
Other undisclosed operating income  3326111
Operating income (loss):287110369439166(28)(121)
Nonoperating income (expense)(0)12913(7)(42)(48)
Other nonoperating income (expense)(0)110(4)50
Interest and debt expense    (6)(14)(49)
Other undisclosed income from continuing operations before equity method investments, income taxes 20  61449
Income (loss) from continuing operations before income taxes:286131398452159(70)(170)
Income tax expense (benefit)(63)(19)(77)238(4) (0)
Net income (loss):223112321690154(70)(170)
Other undisclosed net income attributable to parent8      
Net income (loss) attributable to parent:231112321690154(70)(170)
Undistributed earnings (loss) allocated to participating securities, basic    (0)
Net income (loss) available to common stockholders, basic:231112321690154(70)(170)
Other undisclosed net income available to common stockholders, diluted    0  
Net income (loss) available to common stockholders, diluted:231112321690154(70)(170)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):223112321690154(70)(170)
Other comprehensive income   0   
Comprehensive income (loss):223112321690154(70)(170)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent214(1)0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:226113325690154(70)(170)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: